Low-Dose IL-2 Rebalances Immunity in SLE, With Yuebo Jin, MD Yuebo Jin, MD

Published Date: 21 Nov 2025

Jin discussed new evidence supporting the immune-modulating effects of low-dose IL-2 at ACR 2025.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study: Rapamycin slows the progression of cancer by reducing aging and concentrating on precancerous cells.

2.

Can Alternating Venetoclax Regimens Improve AML Outcomes?

3.

Cancer detection recovered following pandemic disruptions

4.

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

5.

Research identifies nearly 200 potential breast carcinogens in food packaging materials


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot